Show simple item record

dc.contributor.authorEarl, HM
dc.contributor.authorHiller, L
dc.contributor.authorPlummer, C
dc.contributor.authorMiles, D
dc.contributor.authorWardley, Andrew M
dc.contributor.authorCameron, DA
dc.contributor.authorDunn, JA
dc.date.accessioned2020-03-27T09:28:03Z
dc.date.available2020-03-27T09:28:03Z
dc.date.issued2020en
dc.identifier.citationEarl HM, Hiller L, Plummer C, Miles D, Wardley AM, Cameron DA, et al. Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply. Lancet. 2020;395:492-3.en
dc.identifier.pmid32061290en
dc.identifier.doi10.1016/S0140-6736(19)32544-9en
dc.identifier.urihttp://hdl.handle.net/10541/622844
dc.description.abstractComment on Protective strategies to prevent trastuzumab-induced cardiotoxicity. [Lancet. 2020]en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/S0140-6736(19)32544-9en
dc.titleProtective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' replyen
dc.typeArticleen
dc.contributor.departmentDepartment of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridgeen
dc.identifier.journalLanceten
dc.description.noteen]
refterms.dateFOA2020-03-30T14:24:34Z


Files in this item

Thumbnail
Name:
32061290.pdf
Size:
142.2Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record